ArticleJCEM case reports2026

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia.

Marah Alsayed Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.